Prevalence, incidence, and risk factors of malignancy in patients with rheumatoid arthritis: a nationwide cohort study from Korea
Kyung Min Ko, Su-Jin Moon
Korean J Intern Med. 2023;38(1):113-124. Published online 2021 Aug 20 DOI: https://doi.org/10.3904/kjim.2021.146
Citations to this article as recorded by 
Hydroxychloroquine as a potential therapy for ANCA-associated vasculitis
Sahil Jain, Shirish R. Sangle, Sangmi Kim, Susan John, David D’Cruz
Vessel Plus.2024;[Epub] CrossRef
Hydroxychloroquine had neutral effect on long‐term risk of malignancy in rheumatoid arthritis patients: A population‐based retrospective cohort study
Xiu‐Juan Hou, Renin Chang, Yu‐Hsun Wang, Tian‐Lun Kang, James Cheng‐Chung Wei
International Journal of Rheumatic Diseases.2024;[Epub] CrossRef
Causal inference between rheumatoid arthritis and prostate cancer
Junyong Ou, Lang Zou, Yaqian Wu, Qiming Zhang, Yangyi Fang, Min Qiu, Xiaojun Tian, Lulin Ma, Hai Bi, Cheng Liu
Clinical and Experimental Medicine.2023; 23(8): 4681. CrossRef
Potential Cancer Risk in Patients with Rheumatoid Arthritis: A Longitudinal Korean Population-Based Analysis
Hyo Geun Choi, Ho Suk Kang, Hyun Lim, Joo-Hee Kim, Ji Hee Kim, Seong-Jin Cho, Eun Sook Nam, Kyueng-Whan Min, Ha Young Park, Nan Young Kim, Mi Jung Kwon
Journal of Personalized Medicine.2022; 12(6): 965. CrossRef